Skip to main content
CNS Neuroscience & Therapeutics logoLink to CNS Neuroscience & Therapeutics
letter
. 2013 Jun 7;19(8):635–637. doi: 10.1111/cns.12133

Persistent Benign Oligemia Causes CT Perfusion Mismatch in Patients with Intracranial Large Artery Occlusive Disease during Subacute Stroke

Jing‐Jing Li 1, Xiang‐Yan Chen 2, Yannie Soo 2, Jill M Abrigo 3, Thomas W Leung 2, Edward Wong 2, Vincent Mok 2, James SW Cheung 3, Anil T Ahuja 3, Jin‐Sheng Zeng 1, Ka‐Sing Wong 2,
PMCID: PMC6493611  PMID: 23876019

Conflict of Interest

The authors declare no conflict of interest.

CT perfusion (CTP) imaging provides quantitative parameters of cerebral perfusion using cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT). It is increasingly being used in selecting patients for thrombolytic therapy 1, 2. Penumbra is usually characterized as the mismatch area with increased or normal CBV and prolonged MTT 3. MTT ratio (symptomatic ipsilateral MTT compared with the contralateral side), with a threshold more than 145%, affords the most accurate delineation of the tissue at risk of infarction 4. The recently published study 5 described the concept of benign oligemia at acute phase of stroke and distinguished it from penumbra. Intracranial large artery occlusive disease (ICAD) accounts for about one quarter to one‐third of all stroke patients in Asians 6, 7. Little is known about the clinical significance of the mismatch shown on CTP in patients with ICAD during subacute stroke. Will the mismatch area be persistent? Is it a real penumbra?

In the present study, consecutive stroke patients who were referred for CTP in the Prince of Wales Hospital, Hong Kong, in 2009 were screened. Inclusion criteria were as follows: (1) baseline CT angiography (CTA), CTP, and/or additional vascular imaging magnetic resonance angiography (MRA), (2) ICAD was diagnosed when CTA and MRA showed stenosis or occlusion of intracranial large artery, (3) with infarction in corresponding middle cerebral artery (MCA) territory in acute (within 1 day) and subacute group (more than 1 day) of ischemic stroke, and (4) more than 20% mismatch on CTP. Exclusion criteria were as follows: (1) bilateral intracranial occlusive stenosis, (2) unsatisfactory quality of CTP studies, (3) with document source of embolism from cardiac or extracranial artery, and (4) unclear clinical data.

CT perfusion was performed on a multidetector scanner (GE Healthcare, Tokyo, Japan), as a 60‐second cine series, beginning 5 seconds after a 50‐mL injection of IOP300. Source images were transferred to a workstation and were evaluated with CT Perfusion 3 software (GE Healthcare). To obtain arterial input and venous output, we placed 3‐ to 5‐pixel squared regions in unaffected large artery (such as anterior cerebral artery) and vein (such as superior sagittal sinus) respectively. Bilateral MCA territories were circled as region of interest. Any area of old infarct was excluded. spss 12.0 (SPSS Inc, Chicago, IL, USA) was performed for statistical analyses. In all analyses, nonparametric Mann–Whitney U‐test was used for comparison of continuous variables, and chi‐squared test was used for categorical variables. Values were considered significantly different with P < 0.05.

Thirty‐four stroke patients with ICAD and infarction in relevant MCA territory were screened. Four patients were excluded due to poor quality image or incomplete data, and ten patients were excluded due to less than 20% mismatch. Finally, fourteen patients were enrolled in subacute group and six in acute group. An example of mismatch area was shown in Figure 1. Table 1 demonstrated the characteristics of recruited patients and the value of CTP‐related parameters. Due to small sample size, the patients in acute group were older and severer than those in subacute group. The median time between CTP and onset of symptom was 6 days (range, 3–30 days) in subacute group and 180 min in acute group. The values of CBF, CBV, and MTT were comparative between patients in acute and subacute stage. The value of CBV ratio was higher in patients in subacute group than in those in acute group (1.3 versus 1.0, = 0.025). The MTT ratio in both groups was higher than 145%.

Figure 1.

Figure 1

Digitally CT perfusion images of a patient on the fourth day after onset of stroke. Man, 60 years, CT angiography (CTA) and magnetic resonance angiography (MRA) proved 70% stenosis of left middle cerebral artery, NIHSS on admission: 6. Mismatch area can still be detected on the fourth day after onset of stroke. (A) Source image (B) cerebral blood flow (CBF) map (C) cerebral blood volume (CBV) map (D) mean transient time (MTT) map.

Table 1.

Characteristics of patients with ICAD in subacute and acute phase of stroke

Characteristics of ICAD patients Subacute group (N = 14) Acute group (N = 6) P‐value
Age (year) 70.5 78.5 0.021*
Gender (M/F) 7/7 2/4 0.518
Admission NIHSS 4 8 0.028*
CTP time‐to‐onset 6 days 180 min
Distribution of ICAD
Pure stenosis 7 3
Multiple stenosis 7 3
CBF (mL/100 g/min) 28.25 21.05 0.058
CBF ratio 0.77 0.54 0.052
CBV (mL/100 g) 2.04 1.6 0.117
CBV ratio 1.3 1 0.025*
MTT (s) 6.67 7.18 0.322
MTT ratio 1.77 2.13 0.563

ICAD, intracranial large artery occlusive disease; CTP, CT perfusion; CBF, cerebral blood flow; CBV, cerebral blood volume; MTT, mean transient time; NIHSS, National Institutes of Health Stroke Scale.

Data are expressed in median value except for gender. *P < 0.05 compared with the acute group.

This study was a small sample size study, which provided the very preliminary data about the blood perfusion in patients with ICAD. The findings indicated that CTP mismatch can be persistent in the subacute phase of stroke in patients with ICAD, showing similar values of CTP parameters with penumbra. Penumbra is thought to be the area, which will progress to infarction if not salvaged 1. Thus, the long‐lasting mismatch shown in our present study should be overestimated benign oligemia rather than penumbra. Although the overestimated benign oligemia has been proved in acute phase of stroke 5, 8, it is still an ambiguous concept during subacute phase 3, 9. Our present study indicated the possibility of benign oligemia in subacute stage. Further study is needed to delineate the difference between oligemia and penumbra in patients with ICAD.

In conclusion, our study demonstrated the existence of mismatch area with similar characters to penumbra in patients with ICAD during subacute phase of stroke. We suppose the mismatch area should be benign oligemia rather penumbra. In patients with ICAD, more attentions should be paid to interpretation of CTP mismatch, especially during the process of selecting candidate to receive thrombolytic treatment.

Acknowledgments

The study was supported by the S.H. Ho Cardiovascular Disease and Stroke Center, Institute of Vascular Medicine, Chinese University of Hong Kong. Dr Li was supported by the Henry Leung Fellowship program, Department of Medicine & Therapeutics, Chinese University of Hong Kong.

References

  • 1. Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009;8:261–269. [DOI] [PubMed] [Google Scholar]
  • 2. Sztriha LK, Manawadu D, Jarosz J, Keep J, Kalra L. Safety and clinical outcome of thrombolysis in ischaemic stroke using a perfusion CT mismatch between 3 and 6 hours. PLoS ONE 2011;6:e25796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Parsons MW. Perfusion CT: Is it clinically useful? Int J Stroke 2008;3:41–50. [DOI] [PubMed] [Google Scholar]
  • 4. Konstas AA, Lev MH. CT perfusion imaging of acute stroke: The need for arrival time, delay insensitive, and standardized postprocessing algorithms? Radiology 2010;254:22–25. [DOI] [PubMed] [Google Scholar]
  • 5. Kamalian S, Konstas AA, Maas MB, et al. CT perfusion mean transit time maps optimally distinguish benign oligemia from true “at‐risk” ischemic penumbra, but thresholds vary by postprocessing technique. AJNR Am J Neuroradiol 2012;33:545–549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier. Stroke 2008;39:2396–2399. [DOI] [PubMed] [Google Scholar]
  • 7. Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998;50:812–813. [DOI] [PubMed] [Google Scholar]
  • 8. Alawneh JA, Jones PS, Mikkelsen IK, et al. Infarction of ‘non‐core‐non‐penumbral’ tissue after stroke: Multivariate modelling of clinical impact. Brain 2011;134:1765–1776. [DOI] [PubMed] [Google Scholar]
  • 9. Kumar G, Goyal MK, Sahota PK, Jain R. Penumbra, the basis of neuroimaging in acute stroke treatment: Current evidence. J Neurol Sci 2010;288:13–24. [DOI] [PubMed] [Google Scholar]

Articles from CNS Neuroscience & Therapeutics are provided here courtesy of Wiley

RESOURCES